The new hepatitis C drug, Sovaldi, is not the most expensive drug on the market, so why is it getting so much negative feedback? This article is accompanied by charts explaining why Sovaldi is in a league of its own. See more here. (Source: The New York Times, 8/6/14).
You are here: / / Sticker Shock With Sovaldi – The Mass-Market Specialty Drug